Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-101200
Filing Date
2010-11-05
Accepted
2010-11-04 21:52:16
Documents
10
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a57124e10vq.htm 10-Q 514325
2 EX-31.1 a57124exv31w1.htm EX-31.1 6864
3 EX-31.2 a57124exv31w2.htm EX-31.2 6891
4 EX-32.1 a57124exv32w1.htm EX-32.1 4043
5 EX-32.2 a57124exv32w2.htm EX-32.2 4060
  Complete submission text file 0000950123-10-101200.txt   2555101

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT wpi-20100930.xml EX-101.INS 355835
7 EX-101 SCHEMA DOCUMENT wpi-20100930.xsd EX-101.SCH 12264
8 EX-101 CALCULATION LINKBASE DOCUMENT wpi-20100930_cal.xml EX-101.CAL 44850
9 EX-101 LABELS LINKBASE DOCUMENT wpi-20100930_lab.xml EX-101.LAB 134030
10 EX-101 PRESENTATION LINKBASE DOCUMENT wpi-20100930_pre.xml EX-101.PRE 76645
Mailing Address 311 BONNIE CIRCLE CORONA CA 92880
Business Address 311 BONNIE CIRCLE CORONA CA 92880 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13305 | Film No.: 101166580
SIC: 2834 Pharmaceutical Preparations